Page last updated: 2024-08-23

ngp 1-01 and Parkinson Disease

ngp 1-01 has been researched along with Parkinson Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bloomquist, JR; Geldenhuys, WJ; Malan, SF; Murugesan, T; Van der Schyf, CJ	1

Other Studies

1 other study(ies) available for ngp 1-01 and Parkinson Disease

Article	Year
Synthesis and biological evaluation of pentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecane derivatives as potential therapeutic agents in Parkinson's disease. Bioorganic & medicinal chemistry, 2004, Apr-01, Volume: 12, Issue:7 Topics: Animals; Antiparkinson Agents; Bridged-Ring Compounds; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Male; Membrane Glycoproteins; Membrane Transport Proteins; Mice; Mice, Inbred ICR; Mitochondria, Liver; Models, Molecular; Molecular Structure; Monoamine Oxidase; Neostriatum; Nerve Tissue Proteins; Papio; Parkinson Disease; Structure-Activity Relationship; Synaptosomes	2004

Article

Year

Synthesis and biological evaluation of pentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecane derivatives as potential therapeutic agents in Parkinson's disease.

Bioorganic & medicinal chemistry, 2004, Apr-01, Volume: 12, Issue:7

Topics: Animals; Antiparkinson Agents; Bridged-Ring Compounds; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Male; Membrane Glycoproteins; Membrane Transport Proteins; Mice; Mice, Inbred ICR; Mitochondria, Liver; Models, Molecular; Molecular Structure; Monoamine Oxidase; Neostriatum; Nerve Tissue Proteins; Papio; Parkinson Disease; Structure-Activity Relationship; Synaptosomes

2004